PWMG
GILD icon

Prestige Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Prestige Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$914K Buy
7,232
+2,508
+53% +$330K 0.17% 77
2026
Q1 		$658K Sell
4,724
-22
-0.5% -$3.08K 0.13% 87
2025
Q4 		$583K Buy
4,746
+3,601
+314% +$438K 0.11% 93
2025
Q3 		$127K Buy
1,145
+24
+2% +$2.73K 0.02% 200
2025
Q2 		$124K Hold
1,121
– – 0.03% 196
2025
Q1 		$126K Hold
1,121
– – 0.03% 184
2024
Q4 		$104K Hold
1,121
– – 0.02% 200
2024
Q3 		$94K Hold
1,121
– – 0.02% 199
2024
Q2 		$76.9K Sell
1,121
-147
-12% -$9.81K 0.02% 195
2024
Q1 		$92.9K Sell
1,268
-237
-16% -$18.2K 0.02% 213
2023
Q4 		$122K Sell
1,505
-169
-10% -$13.2K 0.03% 171
2023
Q3 		$125K Sell
1,674
-135
-7% -$10.4K 0.03% 169
2023
Q2 		$139K Sell
1,809
-3,566
-66% -$284K 0.03% 178
2023
Q1 		$446K Buy
5,375
+3,552
+195% +$294K 0.11% 90
2022
Q4 		$157K Sell
1,823
-3,163
-63% -$250K 0.04% 153
2022
Q3 		$307K Buy
4,986
+173
+4% +$10.9K 0.09% 105
2022
Q2 		$298K Buy
4,813
+162
+3% +$10K 0.08% 110
2022
Q1 		$276K Buy
4,651
+2,825
+155% +$181K 0.07% 118
2021
Q4 		$133K Sell
1,826
-200
-10% -$13.8K 0.03% 174
2021
Q3 		$141K Sell
2,026
-200
-9% -$14.1K 0.04% 163
2021
Q2 		$154K Hold
2,226
– – 0.04% 153
2021
Q1 		$144K Buy
2,226
+125
+6% +$8.06K 0.04% 149
2020
Q4 		$123K Sell
2,101
-214
-9% -$12.9K 0.03% 157
2020
Q3 		$146K Buy
2,315
+3
+0.1% +$208 0.04% 138
2020
Q2 		$177K Sell
2,312
-137
-6% -$10.5K 0.06% 109
2020
Q1 		$183K Buy
2,449
+682
+39% +$47.1K 0.08% 86
2019
Q4 		$115K Sell
1,767
-1,018
-37% -$66.3K 0.06% 151
2019
Q3 		$177K Hold
2,785
– – 0.1% 115
2019
Q2 		$188K Buy
2,785
+14
+0.5% +$921 0.11% 112
2019
Q1 		$180K Sell
2,771
-85
-3% -$5.65K 0.11% 114
2018
Q4 		$179K Buy
+2,856
New +$200K 0.13% 113

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prestige Wealth Management Group's GILD Position: Q2 2026 in Review

Prestige Wealth Management Group increased its Gilead Sciences (GILD) stake by 53% in Q2 2026, buying an estimated $330K and bringing the position to 7,232 shares worth $914K. The position accounts for 0.17% of the portfolio, ranked #77.

Prestige Wealth Management Group first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prestige Wealth Management Group held 7,232 shares of Gilead Sciences worth $914K as of Q2 2026.
  • Prestige Wealth Management Group bought 2,508 Gilead Sciences shares in Q2 2026, an estimated $330K.
  • Gilead Sciences made up 0.17% of Prestige Wealth Management Group's portfolio in Q2 2026, its #77 holding.
  • Prestige Wealth Management Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.